Wells Fargo lowered the firm’s price target on Sabra Health Care (SBRA) to $20 from $21 and keeps an Overweight rating on the shares. The firm remains most constructive on Senior Housing as market data continues to signal strength in occupancy and rate, and broker contracts flag accelerated deal volumes.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SBRA: